PET scans could revolutionize monitoring of rare inflammatory disease
NCT ID NCT07712172
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study explores whether a special type of PET/CT scan, using a radioactive tracer called 18F-FDG, can accurately measure disease activity in people with granulomatosis with polyangiitis (GPA), a rare condition that causes inflammation of blood vessels. Researchers will compare the scan results with a standard clinical scoring system to see if the imaging technique can provide a more objective way to track the disease. The study involves 31 adults with newly diagnosed or relapsed active GPA.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 18F-FDG (a radioactive tracer used in PET/CT scans)
- What this could lead to
- If successful, this could lead to a more accurate, non-invasive way to monitor GPA disease activity, potentially improving treatment decisions.
- What could go wrong
- This is a small, early observational study, so results may not apply broadly. The scan's sensitivity and correlation with standard scores may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRANULOMATOSIS WITH POLYANGIITIS (WEGENER'S) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh
Chandigarh, Chandigarh, 160012, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.